Defining and running a non-inferiority trial can be challenging. Given a proposed outcome measure, Immunetrics can provide the probability of achieving a significant result for any point in time, over any range of population sizes and success margins.

This includes:

  • Testing a novel compound against a control drug, at any population size, with any margin, to optimize clinical trial design and achieve the optimal probability of success
  • Determining the best non-inferiority margin for your trial in advance of protocol submission